Amoy Diagnostics Co., Ltd. (SHE:300685)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Detection Reagent	951.89M	876.85M	859.88M	611.39M	699.04M
Detection Reagent Growth	8.56%	1.97%	40.64%	-12.54%	23.83%
Testing Service	77.31M	66.56M	84.94M	135.00M	154.91M
Testing Service Growth	16.16%	-21.64%	-37.09%	-12.85%	33.43%
Drug Clinical Research Services	158.14M	160.90M	88.71M	86.04M	54.18M
Drug Clinical Research Services Growth	-1.71%	81.38%	3.10%	58.81%	26.97%
Unallocated Other Operations	10.39M	4.64M	9.99M	9.75M	8.91M
Unallocated Other Operations Growth	123.87%	-53.55%	2.42%	9.47%	74.06%
Total	1.20B	1.11B	1.04B	842.18M	917.03M
Total Growth	8.01%	6.27%	23.91%	-8.16%	25.90%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	925.86M	848.96M	847.26M	697.10M	811.70M
China Growth	9.06%	0.20%	21.54%	-14.12%	30.95%
Overseas	271.87M	259.99M	196.25M	145.08M	105.33M
Overseas Growth	4.57%	32.48%	35.27%	37.74%	-2.95%
Total	1.20B	1.11B	1.04B	842.18M	917.03M
Total Growth	8.01%	6.27%	23.91%	-8.16%	25.90%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 27, 2026

Data Sources Report a data error